Edward J. Dulac III, EVP, Chief Financial Officer at Intellia Therapeutics, Inc. (NTLA), sold 4,677 shares at $18.00 ($84K) on 2026-07-02, disclosed to the SEC on 2026-07-06.
Scheduled sale ($84k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2025-07-25 | $209K | — | Filing → |
| FATE | SELL | 2024-03-05 | $19K | — | Filing → |
| FATE | SELL | 2024-01-30 | $9K | — | Filing → |